• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房获得性衰弱和肌少症的分子机制。

Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia.

机构信息

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Ostrava, 708 52 Ostrava, Czech Republic.

Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic.

出版信息

Int J Mol Sci. 2022 Jul 29;23(15):8396. doi: 10.3390/ijms23158396.

DOI:10.3390/ijms23158396
PMID:35955530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368893/
Abstract

Skeletal muscle is a highly adaptable organ, and its amount declines under catabolic conditions such as critical illness. Aging is accompanied by a gradual loss of muscle, especially when physical activity decreases. Intensive care unit-acquired weakness is a common and highly serious neuromuscular complication in critically ill patients. It is a consequence of critical illness and is characterized by a systemic inflammatory response, leading to metabolic stress, that causes the development of multiple organ dysfunction. Muscle dysfunction is an important component of this syndrome, and the degree of catabolism corresponds to the severity of the condition. The population of critically ill is aging; thus, we face another negative effect-sarcopenia-the age-related decline of skeletal muscle mass and function. Low-grade inflammation gradually accumulates over time, inhibits proteosynthesis, worsens anabolic resistance, and increases insulin resistance. The cumulative consequence is a gradual decline in muscle recovery and muscle mass. The clinical manifestation for both of the above conditions is skeletal muscle weakness, with macromolecular damage, and a common mechanism-mitochondrial dysfunction. In this review, we compare the molecular mechanisms underlying the two types of muscle atrophy, and address questions regarding possible shared molecular mechanisms, and whether critical illness accelerates the aging process.

摘要

骨骼肌是一种高度适应性的器官,在分解代谢状态下(如危重病)其数量会减少。衰老伴随着肌肉的逐渐丧失,尤其是当身体活动减少时。重症监护病房获得性肌无力是危重病患者常见且非常严重的神经肌肉并发症。它是危重病的结果,其特征是全身性炎症反应导致代谢应激,从而导致多器官功能障碍。肌肉功能障碍是该综合征的一个重要组成部分,分解代谢的程度与病情的严重程度相对应。危重病患者群体正在老龄化;因此,我们面临着另一个负面影响——肌肉减少症,即与年龄相关的骨骼肌质量和功能下降。低水平炎症会随着时间的推移逐渐积累,抑制蛋白质合成,加重合成代谢抵抗,并增加胰岛素抵抗。累积的结果是肌肉恢复和肌肉质量逐渐下降。这两种情况的临床表现都是骨骼肌无力、大分子损伤和一个共同的机制——线粒体功能障碍。在这篇综述中,我们比较了两种类型的肌肉萎缩的分子机制,并探讨了可能存在的共同分子机制的问题,以及危重病是否会加速衰老过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/db330c407831/ijms-23-08396-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/5edd368ce6c8/ijms-23-08396-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/fd7987ae478d/ijms-23-08396-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/aef3178338ff/ijms-23-08396-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/10e19dfe2199/ijms-23-08396-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/1258087a53c9/ijms-23-08396-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/8791398a5544/ijms-23-08396-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/db330c407831/ijms-23-08396-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/5edd368ce6c8/ijms-23-08396-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/fd7987ae478d/ijms-23-08396-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/aef3178338ff/ijms-23-08396-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/10e19dfe2199/ijms-23-08396-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/1258087a53c9/ijms-23-08396-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/8791398a5544/ijms-23-08396-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a2b/9368893/db330c407831/ijms-23-08396-g007.jpg

相似文献

1
Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia.重症监护病房获得性衰弱和肌少症的分子机制。
Int J Mol Sci. 2022 Jul 29;23(15):8396. doi: 10.3390/ijms23158396.
2
Intensive care unit-acquired weakness: unanswered questions and targets for future research.重症监护病房获得性肌无力:未解决的问题及未来研究方向
F1000Res. 2019 Apr 17;8. doi: 10.12688/f1000research.17376.1. eCollection 2019.
3
Intensive Care Unit Acquired Weakness Is Associated with Rapid Changes to Skeletal Muscle Proteostasis.重症加强护理病房获得性肌无力与骨骼肌蛋白平衡的快速变化有关。
Cells. 2022 Dec 11;11(24):4005. doi: 10.3390/cells11244005.
4
Sarcopenia in critically ill patients.危重症患者的肌肉减少症
J Anesth. 2016 Oct;30(5):884-90. doi: 10.1007/s00540-016-2211-4. Epub 2016 Jul 4.
5
Critical illness neuromyopathy and muscle weakness in patients in the intensive care unit.重症监护病房患者的危重病性神经肌肉病与肌无力
AACN Adv Crit Care. 2009 Jul-Sep;20(3):243-53. doi: 10.1097/NCI.0b013e3181ac2551.
6
Unraveling the causes of sarcopenia: Roles of neuromuscular junction impairment and mitochondrial dysfunction.解析肌少症的病因:神经肌肉接头损伤和线粒体功能障碍的作用。
Physiol Rep. 2024 Jan;12(1):e15917. doi: 10.14814/phy2.15917.
7
Sleep and Intensive Care Unit-Acquired Weakness in Critically Ill Older Adults.危重症老年患者的睡眠与重症监护病房获得性肌无力
Dimens Crit Care Nurs. 2019 Jan/Feb;38(1):20-28. doi: 10.1097/DCC.0000000000000335.
8
Feeding the critically ill obese patient: a systematic review protocol.为危重症肥胖患者提供营养支持:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):95-109. doi: 10.11124/jbisrir-2015-2458.
9
Effectiveness of physical exercise and neuromuscular electrical stimulation interventions for preventing and treating intensive care unit-acquired weakness: A systematic review of randomized controlled trials.体育锻炼和神经肌肉电刺激干预对预防和治疗重症监护病房获得性肌无力的有效性:随机对照试验的系统评价
Intensive Crit Care Nurs. 2023 Feb;74:103333. doi: 10.1016/j.iccn.2022.103333. Epub 2022 Oct 22.
10
From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective.从危重病后骨骼肌无力到功能结局:转化生物学视角。
Thorax. 2019 Nov;74(11):1091-1098. doi: 10.1136/thoraxjnl-2016-208312. Epub 2019 Aug 20.

引用本文的文献

1
Potential relationship between cuproptosis and sepsis-acquired weakness: an intermediate role for mitochondria.铜死亡与脓毒症获得性肌无力之间的潜在关系:线粒体的中间作用
Front Physiol. 2025 Mar 20;16:1520669. doi: 10.3389/fphys.2025.1520669. eCollection 2025.
2
Role of GLP‑1 receptor agonists in sepsis and their therapeutic potential in sepsis‑induced muscle atrophy (Review).胰高血糖素样肽-1受体激动剂在脓毒症中的作用及其对脓毒症诱导的肌肉萎缩的治疗潜力(综述)
Int J Mol Med. 2025 May;55(5). doi: 10.3892/ijmm.2025.5515. Epub 2025 Mar 7.
3
FOXO regulation of TXNIP induces ferroptosis in satellite cells by inhibiting glutathione metabolism, promoting Sarcopenia.

本文引用的文献

1
Intensive care unit-acquired weakness and the COVID-19 pandemic: A clinical review.重症监护病房获得性肌无力与 COVID-19 大流行:临床综述。
PM R. 2022 Feb;14(2):227-238. doi: 10.1002/pmrj.12757. Epub 2022 Jan 31.
2
Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging.线粒体动态和骨骼肌健康与衰老中的自噬
Int J Mol Sci. 2021 Jul 30;22(15):8179. doi: 10.3390/ijms22158179.
3
Regulation of muscle and mitochondrial health by the mitochondrial fission protein Drp1 in aged mice.线粒体分裂蛋白 Drp1 调控衰老小鼠的肌肉和线粒体健康。
FOXO对TXNIP的调控通过抑制谷胱甘肽代谢诱导卫星细胞发生铁死亡,促进肌肉减少症。
Cell Mol Life Sci. 2025 Feb 21;82(1):81. doi: 10.1007/s00018-025-05592-1.
4
Predicting early diagnosis of intensive care unit-acquired weakness in septic patients using critical ultrasound and biological markers.使用床旁超声和生物标志物预测脓毒症患者重症监护病房获得性肌无力的早期诊断
BMC Anesthesiol. 2025 Jan 25;25(1):39. doi: 10.1186/s12871-025-02911-8.
5
Advancing critical care recovery: The pivotal role of machine learning in early detection of intensive care unit-acquired weakness.推进重症监护恢复:机器学习在重症监护病房获得性肌无力早期检测中的关键作用。
World J Clin Cases. 2024 Jul 26;12(21):4455-4459. doi: 10.12998/wjcc.v12.i21.4455.
6
Construction and evaluation of acquired weakness nomogram model in patients with mechanical ventilation in intensive care unit.重症监护病房机械通气患者获得性虚弱列线图模型的构建与评估
Digit Health. 2024 Jul 23;10:20552076241261604. doi: 10.1177/20552076241261604. eCollection 2024 Jan-Dec.
7
Longitudinal Assessment of Blood-Based Inflammatory, Neuromuscular, and Neurovascular Biomarker Profiles in Intensive Care Unit-Acquired Weakness: A Prospective Single-Center Cohort Study.重症监护病房获得性肌无力患者基于血液的炎症、神经肌肉和神经血管生物标志物谱的纵向评估:一项前瞻性单中心队列研究。
Neurocrit Care. 2025 Feb;42(1):118-130. doi: 10.1007/s12028-024-02050-x. Epub 2024 Jul 9.
8
Suppression of Ventilation-Induced Diaphragm Fibrosis through the Phosphoinositide 3-Kinase-γ in a Murine Bleomycin-Induced Acute Lung Injury Model.通过磷酸肌醇 3-激酶-γ抑制通气诱导的膈纤维化在小鼠博来霉素诱导的急性肺损伤模型中。
Int J Mol Sci. 2024 Jun 8;25(12):6370. doi: 10.3390/ijms25126370.
9
Effect of dimethyl fumarate on mitochondrial metabolism in a pediatric porcine model of asphyxia-induced in-hospital cardiac arrest.富马酸二甲酯对窒息诱导的院内心脏骤停小儿猪模型中线粒体代谢的影响。
Sci Rep. 2024 Jun 15;14(1):13852. doi: 10.1038/s41598-024-64317-9.
10
Risk factors for ICU-acquired weakness in sepsis patients: A retrospective study of 264 patients.脓毒症患者发生重症监护病房获得性肌无力的危险因素:一项对264例患者的回顾性研究。
Heliyon. 2024 May 31;10(11):e32253. doi: 10.1016/j.heliyon.2024.e32253. eCollection 2024 Jun 15.
J Physiol. 2021 Sep;599(17):4045-4063. doi: 10.1113/JP281752. Epub 2021 Aug 4.
4
Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics.受体介导的肌肉动态平衡作为肌肉减少症治疗的靶点。
Endocrinol Metab (Seoul). 2021 Jun;36(3):478-490. doi: 10.3803/EnM.2021.1081. Epub 2021 Jun 28.
5
Role of the Heart in Lactate Shuttling.心脏在乳酸穿梭中的作用。
Front Nutr. 2021 Apr 22;8:663560. doi: 10.3389/fnut.2021.663560. eCollection 2021.
6
Build-UPS and break-downs: metabolism impacts on proteostasis and aging.构建与解体:代谢对蛋白质稳态和衰老的影响。
Cell Death Differ. 2021 Feb;28(2):505-521. doi: 10.1038/s41418-020-00682-y. Epub 2021 Jan 4.
7
Intensive Care Unit-Acquired Weakness: A Review of Recent Progress With a Look Toward the Future.重症监护病房获得性肌无力:近期进展回顾与未来展望
Front Med (Lausanne). 2020 Nov 23;7:559789. doi: 10.3389/fmed.2020.559789. eCollection 2020.
8
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study.阿那白滞素治疗危重症 COVID-19 患者:一项前瞻性队列研究。
Crit Care. 2020 Dec 10;24(1):688. doi: 10.1186/s13054-020-03364-w.
9
Sarcopenia: Molecular Pathways and Potential Targets for Intervention.肌肉减少症:干预的分子途径和潜在靶点。
Int J Mol Sci. 2020 Nov 22;21(22):8844. doi: 10.3390/ijms21228844.
10
Intensive Care Unit-Acquired Weakness: Not just Another Muscle Atrophying Condition.重症监护病房获得性衰弱:不仅仅是另一种肌肉萎缩症。
Int J Mol Sci. 2020 Oct 22;21(21):7840. doi: 10.3390/ijms21217840.